{"DataElement":{"publicId":"2541843","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Therapy Responsible Person Modification Type","preferredDefinition":"the person responsible for a modification or change to a therapy in an AIDS (acquired immunodeficiency syndrome, resulting from the acquired deficiency of cellular immunity caused by the HIV/human immunodeficiency virus) trial.","longName":"AIDS_TX_R_PRS_MOD_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2541845","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Therapy Responsible Person Modification","preferredDefinition":"information relating to the person responsible for a modification or change to a therapy in an AIDS (acquired immunodeficiency syndrome, resulting from the acquired deficiency of cellular immunity caused by the HIV/human immunodeficiency virus) trial.","longName":"AIDS_TX_RES_PERS_MOD","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3081929","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Therapy","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C2851:C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85C9A655-BAE9-A9AE-E040-BB89AD430F8A","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-04","modifiedBy":"ONEDATA","dateModified":"2010-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2541842","version":"1","preferredName":"Responsible Person Modification","preferredDefinition":"A person worthy of responsibility or trust or one held accountable.:Modification; the act of making something different.","longName":"C25657:C25572","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Responsible Person","conceptCode":"C25657","definition":"A person worthy of responsibility or trust or one held accountable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Modification","conceptCode":"C25572","definition":"Modification; the act of making something different.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"22272FA9-2726-0AF7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-13","modifiedBy":"ONEDATA","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2227365C-DE35-0CB0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2541847","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Therapy Responsible Person Modification Type","preferredDefinition":"the person responsible for a modification or change to a therapy in an AIDS (acquired immunodeficiency syndrome, resulting from the acquired deficiency of cellular immunity caused by the HIV/human immunodeficiency virus) trial.","longName":"AIDS_TX_R_PRS_MOD_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Patient initiated","valueDescription":"Patient initiated","ValueMeaning":{"publicId":"2581845","version":"1","preferredName":"Patient initiated","longName":"2581845","preferredDefinition":"Patient initiated","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0CC2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-13","modifiedBy":"SHIDED","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2224FCAC-B611-4A5C-E044-0003BA3F9857","beginDate":"2006-11-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-13","modifiedBy":"ONEDATA","dateModified":"2006-11-13","deletedIndicator":"No"},{"value":"Physician initiated","valueDescription":"Physician initiated","ValueMeaning":{"publicId":"2581846","version":"1","preferredName":"Physician initiated","longName":"2581846","preferredDefinition":"Physician initiated","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0CC3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-13","modifiedBy":"SHIDED","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2224FCAC-B623-4A5C-E044-0003BA3F9857","beginDate":"2006-11-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-13","modifiedBy":"ONEDATA","dateModified":"2006-11-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"22273ED4-DC10-0A39-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-13","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"If modification was made to s","type":"Preferred Question Text","description":"If modification was made to study therapy, who initiated modification","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"222733EF-7B2A-0AD1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-13","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}